Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119892) titled 'Study on the mechanism and application of Limosilactobacillus fermentum in modulating the gut Microbiota of postoperative patients with Colorectal Cancer' on March 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Hospital of Lanzhou University
Condition:
Colorectal Cancer
Intervention:
Investigational group:Consumption of yogurt containing Limosilactobacillus fermentum GR-3.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-09
Target Sample Size: Investigational group:25;Control group:25;
Countries of Recruitment:
China
To know ...